secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-02-14T23:59:59+00:00
Accession:  0001493152-24-006677
Event type: debt
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX extends convertible note repayment to May 9, 2024 and draws $500K
----------------------------------------------------------------------

- Sixth Amendment to Secured Convertible Promissory Note extends Repayment Date to May 9, 2024.
- On Feb 13, 2024, AgeX drew $500,000 from available credit under the Secured Note.
- Amendment between AgeX Therapeutics and Juvenescence Limited, effective Feb 9, 2024.
- Borrower reaffirms obligations and security interest in collateral; no default continuing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224006677/0001493152-24-006677-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224006677/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-006677

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer